Edema Associated with Congestive Heart Failure

• FDA approval · 2026-07-23
  FDA Approved: FUROSCIX — Supplemental Application (scPharmaceuticals Inc., a wholly owned subsidiary of MannKind Corporation)

  Supplemental application for FUROSCIX (furosemide injection 80 mg/10 mL) seeking approval for a new or expanded indication or formulation.

• FDA approval · 2026-01-12
  FDA Approved: ACETAZOLAMIDE — Supplemental Application (Ajanta Pharma USA Inc.)

  FDA approved Ajanta Pharma USA Inc.'s supplemental application for acetazolamide. This action approves changes to the product associated wit…

• FDA approval · 2025-01-27
  FDA Approved: ACETAZOLAMIDE — Supplemental Application (Accord Healthcare Inc.)

  FDA approved a supplemental application for Acetazolamide from Accord Healthcare Inc. under an Abbreviated New Drug Application.

• FDA approval · 2024-11-26
  FDA Approved: ACETAZOLAMIDE EXTENDED-RELEASE — Supplemental Application (Micro Labs Limited)

  FDA approved a supplemental application from Micro Labs Limited for an extended-release formulation of acetazolamide.

• FDA approval · 2023-05-19
  FDA Approved: ACETAZOLAMIDE — Supplemental Application (Accord Healthcare Inc.)

  FDA approved a supplemental application for Acetazolamide from Accord Healthcare Inc., a generic drug.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2017-11-20
  FDA Approved: ACETAZOLAMIDE — Original Application (Strides Pharma Science Limited)

  FDA approved an original application for acetazolamide from Strides Pharma Science Limited, establishing a generic version of the drug. The …